Overview

Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone

Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The study aims to evaluate the effect of an increased dose of vaginal progesterone supplementation on the incidence of ongoing pregnancy for patients with a suboptimal serum progesterone level (defined as < 10 mcg/l) on the day of blastocyst transfer.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Ghent
Treatments:
Progesterone